Meghan Gavaghan

654 total citations
19 papers, 477 citations indexed

About

Meghan Gavaghan is a scholar working on Economics and Econometrics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Meghan Gavaghan has authored 19 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 5 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Meghan Gavaghan's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Cardiac Arrhythmias and Treatments (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Meghan Gavaghan is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Cardiac Arrhythmias and Treatments (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Meghan Gavaghan collaborates with scholars based in United States, United Kingdom and France. Meghan Gavaghan's co-authors include Dilip Nathwani, Katherine A. Sulham, Vandana Menon, Gowri Raman, Manish M. Sood, Vivek Y. Reddy, Paul Komenda, Stacey L. Amorosi, R. Akehurst and David R. Holmes and has published in prestigious journals such as Journal of the American College of Cardiology, Stroke and Kidney International.

In The Last Decade

Meghan Gavaghan

16 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meghan Gavaghan United States 8 153 115 96 73 67 19 477
Elie Saade United States 13 124 0.8× 58 0.5× 178 1.9× 130 1.8× 48 0.7× 42 665
Carol L. Moore United States 14 50 0.3× 117 1.0× 157 1.6× 13 0.2× 51 0.8× 20 818
Cumhur Y. Demirkale United States 10 98 0.6× 67 0.6× 174 1.8× 22 0.3× 125 1.9× 19 488
Anne Lotthé France 11 92 0.6× 61 0.5× 100 1.0× 9 0.1× 56 0.8× 16 504
Bishnu Panigrahi India 7 70 0.5× 38 0.3× 52 0.5× 71 1.0× 65 1.0× 11 395
W. John Spicer Australia 13 70 0.5× 55 0.5× 107 1.1× 35 0.5× 25 0.4× 34 469
Vanthida Huang United States 15 177 1.2× 103 0.9× 170 1.8× 13 0.2× 73 1.1× 34 702
Miguel Sánchez Spain 8 84 0.5× 41 0.4× 153 1.6× 18 0.2× 39 0.6× 16 421
Laura Gavaldà Spain 15 159 1.0× 85 0.7× 100 1.0× 20 0.3× 101 1.5× 22 533

Countries citing papers authored by Meghan Gavaghan

Since Specialization
Citations

This map shows the geographic impact of Meghan Gavaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan Gavaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan Gavaghan more than expected).

Fields of papers citing papers by Meghan Gavaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan Gavaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan Gavaghan. The network helps show where Meghan Gavaghan may publish in the future.

Co-authorship network of co-authors of Meghan Gavaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan Gavaghan. A scholar is included among the top collaborators of Meghan Gavaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan Gavaghan. Meghan Gavaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gavaghan, Meghan, Jingyan Yang, Richard H. Stanford, et al.. (2024). Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization and Mortality: A Systematic Literature Review. American Journal of Therapeutics. 31(3). e246–e257. 3 indexed citations
2.
Reddy, Vivek Y., et al.. (2024). Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies. ClinicoEconomics and Outcomes Research. Volume 16. 81–96.
3.
Fusco, Manuela Di, Jingyan Yang, Santiago M. C. Lopez, et al.. (2023). The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review. Journal of Medical Economics. 26(1). 1519–1531. 7 indexed citations
4.
Gavaghan, Meghan, et al.. (2023). 516. A Systematic Literature Review Evaluating Real-World Use of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Death. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
5.
Kamae, Isao, Hidehiko Hara, Koichi Inoue, et al.. (2023). Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan. Journal of Medical Economics. 26(1). 1357–1367. 3 indexed citations
6.
7.
Shore, Neal D. & Meghan Gavaghan. (2022). Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity?. Urologic Oncology Seminars and Original Investigations. 41(4). 207.e9–207.e16. 5 indexed citations
8.
Williams, Stephen B., et al.. (2021). Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 40(1). 10.e7–10.e12. 7 indexed citations
9.
Geier, Andreas, Mary E. Rinella, Maria‐Magdalena Balp, et al.. (2020). Real-World Burden of Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology. 19(5). 1020–1029.e7. 32 indexed citations
10.
Reddy, Vivek Y., R. Akehurst, Meghan Gavaghan, Stacey L. Amorosi, & David R. Holmes. (2019). Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data. Journal of the American Heart Association. 8(13). e011577–e011577. 33 indexed citations
11.
Evans, Roger W., et al.. (2018). A Cost-Effectiveness Analysis of Organ Preservation Methods for Deceased Donor Kidneys at High Risk for Delayed Graft Function in Brazil. Transplantation Proceedings. 50(10). 3121–3127. 6 indexed citations
12.
13.
Reddy, Vivek Y., Meghan Gavaghan, Stacey L. Amorosi, Kenneth M. Steín, & David Holmes. (2017). TCT-188 Budget Impact of Stroke Reduction Strategies in Atrial Fibrillation: Medicare and Patient Perspectives. Journal of the American College of Cardiology. 70(18). B80–B80. 4 indexed citations
14.
15.
Nathwani, Dilip, Gowri Raman, Katherine A. Sulham, Meghan Gavaghan, & Vandana Menon. (2014). Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrobial Resistance and Infection Control. 3(1). 32–32. 259 indexed citations
16.
17.
Gavaghan, Meghan, et al.. (2013). Health economic modeling methods from an ACO provider perspective. Value in Health. 16(3). A28–A28. 1 indexed citations
18.
Gavaghan, Meghan, et al.. (2013). The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation.. PubMed. 20(2). 6682–9. 30 indexed citations
19.
Komenda, Paul, et al.. (2011). An economic assessment model for in-center, conventional home, and more frequent home hemodialysis. Kidney International. 81(3). 307–313. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elie Saade Breakdown of academic impact, for papers by Carol L. Moore Breakdown of academic impact, for papers by Cumhur Y. Demirkale Breakdown of academic impact, for papers by Anne Lotthé Breakdown of academic impact, for papers by Bishnu Panigrahi Breakdown of academic impact, for papers by W. John Spicer Breakdown of academic impact, for papers by Vanthida Huang Breakdown of academic impact, for papers by Miguel Sánchez Breakdown of academic impact, for papers by Laura Gavaldà
Rankless by CCL
2026